CDKL1 promotes tumor proliferation and invasion in colorectal cancer

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FearonERMolecular genetics of colorectal cancerAnnu Rev Pathol2011647950721090969
   PubMed Web of Science ®Google Scholar
• MeyersonMEndersGHWuCLA family of human cdc2-related protein kinasesEMBO J1992118290929171639063
   PubMed Web of Science ®Google Scholar
• YenSHKenesseyALeeSCDicksonDWThe distribution and biochemical properties of a Cdc2-related kinase, KKIALRE, in normal and Alzheimer brainsJ Neurochem1995656257725847595554
   PubMedGoogle Scholar
• HsuLSLiangCJTsengCYYehCWTsaiJNZebrafish cyclin-dependent protein kinase-like 1 (zcdkl1): identification and functional characterizationInt J Mol Sci20111263606361721747697
   PubMedGoogle Scholar
• TaoJVan EschHHagedorn-GreiweMMutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardationAm J Hum Genet20047561149115415499549
   PubMed Web of Science ®Google Scholar
• TangLGaoYYanFTangJEvaluation of cyclin-dependent kinase-like 1 expression in breast cancer tissues and its regulation in cancer cell growthCancer Biother Radiopharm201227639239822804458
   PubMedGoogle Scholar
• SunWYaoLJiangBShaoHZhaoYWangQA role for Cdkl1 in the development of gastric cancerActa Oncol201251679079622369697
   PubMed Web of Science ®Google Scholar
• SongZLinJSunZNiJShaYRNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cellsJ Dermatol Sci2015791576325920913
   PubMedGoogle Scholar
• MalumbresMBarbacidMCell cycle, CDKs and cancer: a changing paradigmNat Rev Cancer20099315316619238148
   PubMed Web of Science ®Google Scholar
• SungWWLinYMWuPRHigh nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patientsBMC Cancer20141495125511643
   PubMed Web of Science ®Google Scholar
• FiresteinRBassAJKimSYCDK8 is a colorectal cancer oncogene that regulates beta-catenin activityNature2008455721254755118794900
   PubMed Web of Science ®Google Scholar
• VlachosPJosephBThe Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamicsOncogene200928474175418819734939
   PubMedGoogle Scholar
• MikhailSAlbaneseCPishvaianMJCyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancersAm J Pathol201518551185119725747534
   PubMed Web of Science ®Google Scholar
• AsgharUWitkiewiczAKTurnerNCKnudsenESThe history and future of targeting cyclin-dependent kinases in cancer therapyNat Rev Drug Discov201514213014625633797
   PubMed Web of Science ®Google Scholar
• GaoXHLiuQZChangWExpression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarrayCancer2013119122212222223576061
   PubMed Web of Science ®Google Scholar
• Knut and Alice Wallenberg Foundation [webpage on the Internet]Assays and AnnotationThe Human Protein Atlas Available from: http://www.proteinatlas.org/about/assays+annotationAccessed January 16, 2015
   Google Scholar
• ChenYShiLZhangLThe molecular mechanism governing the oncogenic potential of SOX2 in breast cancerJ Biol Chem200828326179691797818456656
   PubMed Web of Science ®Google Scholar
• VarjosaloMKeskitaloSVan DrogenAThe protein interaction landscape of the human CMGC kinase groupCell Rep2013341306132023602568
   PubMed Web of Science ®Google Scholar
• MalumbresMCyclin-dependent kinasesGenome Biol201415612225180339
   PubMed Web of Science ®Google Scholar
• PooleAJHeapDCarrollRETynerALTumor suppressor functions for the Cdk inhibitor p21 in the mouse colonOncogene200423498128813415377995
   PubMedGoogle Scholar
• BendrisNLemmersBBlanchardJMCell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitorsCell Cycle201514121786179825789852
   PubMed Web of Science ®Google Scholar
• DeMicheleAClarkASTanKSCDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentClin Cancer Res2015215995100125501126
   PubMed Web of Science ®Google Scholar
• FryDWHarveyPJKellerPRSpecific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenograftsMol Cancer Ther20043111427143815542782
   PubMed Web of Science ®Google Scholar
• KastanMBBartekJCell-cycle checkpoints and cancerNature2004432701531632315549093
   PubMed Web of Science ®Google Scholar
• Rosu-MylesMTaylorBJWolffLLoss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitorsExp Hematol200735339440617309820
   PubMedGoogle Scholar
• WolffLBiesJp15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressorBlood Cells Mol Dis201350422723123403260
   PubMed Web of Science ®Google Scholar
• CobrinikDPocket proteins and cell cycle controlOncogene200524172796280915838516
   PubMed Web of Science ®Google Scholar
• BurkhartDLSageJCellular mechanisms of tumour suppression by the retinoblastoma geneNat Rev Cancer20088967168218650841
   PubMed Web of Science ®Google Scholar
• BurkeJRDeshongAJPeltonJGRubinSMPhosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain bindingJ Biol Chem201028521162861629320223825
   PubMedGoogle Scholar
• HarbourJWLuoRXDei SantiAPostigoAADeanDCCdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1Cell199998685986910499802
   PubMed Web of Science ®Google Scholar
• RubinSMDeciphering the retinoblastoma protein phosphorylation codeTrends Biochem Sci2013381121923218751
   PubMed Web of Science ®Google Scholar
• LeesJABuchkovichKJMarshakDRAndersonCWHarlowEThe retinoblastoma protein is phosphorylated on multiple sites by human cdc2EMBO J19911013427942901756735
   PubMedGoogle Scholar
• FridayBBAdjeiAAAdvances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapyClin Cancer Res200814234234618223206
   PubMedGoogle Scholar